MedPath

Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)

Not Applicable
Not yet recruiting
Conditions
Cardiovascular Disease
Hypertension
Interventions
Other: Peer Delivery of Medications
Other: Health Information Technology (HIT) Platform
Registration Number
NCT06485700
Lead Sponsor
NYU Langone Health
Brief Summary

Peer-based medication delivery decreases the cost of transportation and the opportunity cost of travel while HIT can support peer activities by facilitating targeted adherence counseling, teleconsultation, synchronization of clinical care, and pharmacy activities. The investigators have implemented a pilot program of door-to-door peer-based medication delivery and HIT in western Kenya, and preliminary data indicate improved adherence and blood pressure. However, the effectiveness of this implementation strategy is not fully established. Therefore, the objective of the study is to use the PRECEDE-PROCEED framework to conduct transdisciplinary implementation research to test the hypothesis that integrating peer delivery of medications with HIT (PT4A) improves medication adherence and reduces blood pressure among patients with uncontrolled hypertension in western Kenya.

Detailed Description

Aim 1 will evaluate the effectiveness of PT4A by conducting a two-arm cluster randomized controlled implementation research hybrid type 2 trial, comparing PT4A to control. The primary biological outcome is one-year change in systolic blood pressure. The primary adherence outcome is the pill count adherence ratio. The primary implementation outcome is fidelity. Secondary outcomes are blood pressure control, self-reported adherence, and RE-AIM metrics. Aim 2 will evaluate potential mechanistic relationships between implementation measures and outcomes. Sub Aim 2.1 will evaluate if trust in the health system and patient activation mediate the relationship between PT4A and the outcomes. Aim 3 will consist of cost-effectiveness, budget impact, and qualitative analyses to help inform adaptation of PT4A to other settings. The research will be conducted by a transdisciplinary team with diverse and complementary expertise. The investigators intend to add to existing knowledge of innovative and scalable strategies to improve medication adherence for global hypertension control.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
1140
Inclusion Criteria

• Adult participants enrolled in AMPATH's CDM Program with uncontrolled hypertension (SBP ≥ 140 or diastolic BP (DBP) ≥ 90)

Exclusion Criteria
  • hypertensive emergency requiring immediate medical attention,
  • terminal illness, and
  • inability to provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PT4APeer Delivery of MedicationsPeer delivery of medications supported by Health Information Technology (HIT) platform.
PT4AHealth Information Technology (HIT) PlatformPeer delivery of medications supported by Health Information Technology (HIT) platform.
Primary Outcome Measures
NameTimeMethod
Mean Change in SBP from Baseline to Month 12Baseline, Month 12
Pill Count Adherence Ratio (PCAR) at Month 12Month 12

PCAR is calculated as the percentage of pills taken over the previous month and is measured over a 30-day time period.

Number of Patient E-SignaturesUp to Month 12

Measure of fidelity.

Number of Completed HIT FormsUp to Month 12

Measure of fidelity.

Secondary Outcome Measures
NameTimeMethod
Mean Change in SBP from Baseline to Month 6Baseline, Month 6
Percentage of Participants with Controlled Blood Pressure (BP) at Month 6Month 6

BP measured using automatic BP monitor.

Percentage of Participants with Controlled BP at Month 12Month 12

BP measured using automatic BP monitor.

Trial Locations

Locations (1)

Study Site

🇰🇪

Eldoret, Uasin Gishu County, Kenya

© Copyright 2025. All Rights Reserved by MedPath